Assembly Biosciences (ASMB) Invested Capital (2010 - 2011)
Assembly Biosciences (ASMB) posted quarterly Invested Capital of $419380.0 for Q4 2010.
Powered by 
Analysis
Assembly Biosciences (ASMB) Invested Capital (2010 - 2011) Analysis & Trends
Assembly Biosciences' Invested Capital history runs 1 years deep, the most recent figure standing at $419380.0 for Q4 2010.
- In Q4 2010, Invested Capital changed N/A year-over-year to $419380.0; the TTM figure through Sep 2011 stood at $419380.0 (changed N/A YoY), while the FY2010 annual figure was $419380.0, changed N/A from the prior year.
- Invested Capital for Q4 2010 stood at $419380.0.
- The five-year high for Invested Capital was $419380.0 in Q4 2010, with the low at $419380.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Assembly Biosciences | 687.78 Mn | 367.42 Mn | - | - |